These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5082302)

  • 1. Prevention of dog serum-induced aggregation of pig platelets.
    Gerloff J; Von Kaulla KN
    Proc Soc Exp Biol Med; 1972 Oct; 141(1):298-303. PubMed ID: 5082302
    [No Abstract]   [Full Text] [Related]  

  • 2. [In-vitro inhibition of thrombocyte aggregation induced by xenogenic serum].
    von Kaulla KN; Gerloff J
    Res Exp Med (Berl); 1972; 158(2):152-64. PubMed ID: 4116282
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of bacterial endotoxin and liquoid with blood platelets: aggregation and decrease in the electrokinetic charge.
    Gröttum KA; Hjort PF; Jeremic M
    Thromb Diath Haemorrh; 1969 Aug; 22(1):192-202. PubMed ID: 4980618
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of polysulfonate derivative (GL 2021) on coagulation in vitro and thrombosis in vivo.
    Radziwon P; Schenk J; Boczkowska-Radziwon B; Wojtukiewicz MZ; Giedrojc J; Kloczko J; Breddin HK
    Thromb Res; 2000 Jul; 99(1):99-104. PubMed ID: 10904107
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet adherence in the pig liver perfused with human blood.
    Hickman R; Parker JR; Saunders SJ; Terblanche J
    Transplantation; 1972 Feb; 13(2):195-8. PubMed ID: 5059355
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombogenicity of polysaccharide-coated surfaces.
    Keuren JF; Wielders SJ; Willems GM; Morra M; Cahalan L; Cahalan P; Lindhout T
    Biomaterials; 2003 May; 24(11):1917-24. PubMed ID: 12615482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of platelet charge in the maintenance of blood stability].
    Larcan A; Stoltz JF; Stoltz M
    C R Acad Hebd Seances Acad Sci D; 1971 Jan; 272(1):163-6. PubMed ID: 4994963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum lipids following experimental fibrinolysis].
    Suschke J; Kunze D; von Pilar CE; Krejci K
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):388-9. PubMed ID: 4270871
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and anticoagulant activity of bioisosteric sulfonic-Acid analogues of the antithrombin-binding pentasaccharide domain of heparin.
    Herczeg M; Lázár L; Bereczky Z; Kövér KE; Timári I; Kappelmayer J; Lipták A; Antus S; Borbás A
    Chemistry; 2012 Aug; 18(34):10643-52. PubMed ID: 22782535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies to transplantation antigens by platelet aggregometry.
    Broersma R; Mammen E; Steiman R; Rosenberg JC
    J Surg Res; 1971 Apr; 11(4):173-8. PubMed ID: 5573777
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelets and contact activation of blood clotting. Influence of some aggregation inhibitors.
    Coccheri S; Alessandri M; De Rosa V
    Acta Med Scand Suppl; 1971; 525():253-6. PubMed ID: 5292097
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Effects of heparin derived from different tissues on plasma-phospholipids and platelet aggregation.
    Gillett MP; Besterman EM
    Lancet; 1973 Nov; 2(7839):1204-5. PubMed ID: 4127572
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of anti-inflammatory drugs on the aggregation and adhesiveness of platelets, red cells and leukocytes.
    Kovács IB; Görög P
    Acta Univ Carol Med Monogr; 1972; 52():69-73. PubMed ID: 4205900
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
    Katsube N; Sakaguchi K; Fujitani B; Aishita H
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation and release triggered by antibody to platelet factor 4 (PF4).
    Niewiarowski S; Lukasiewicz H; Nath N
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):188-94. PubMed ID: 4140521
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of platelet adherence to a collagen-coated surface by agents that inhibit platelet shape change and clot retraction.
    Cazenave JP; Packham MA; Guccione MA; Mustard JF
    J Lab Clin Med; 1974 Oct; 84(4):483-93. PubMed ID: 4370106
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of platelet function (mode of action of platelet inhibitors) (author's transl)].
    Baumgartner HR
    Ther Umsch; 1977 May; 34(5):341-6. PubMed ID: 867315
    [No Abstract]   [Full Text] [Related]  

  • 20. Aggregation of human blood platelets by immune complexes in the sedimentation pattern test.
    Myllylä G
    Scand J Haematol Suppl; 1973; 19():1-56. PubMed ID: 4127837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.